Innovative Medical Management Co.,Ltd. (SHE:002173)
China · Delayed Price · Currency is CNY 17.26
+0.18 (1.05%)
Sep 30, 2026, 3:04 PM CST
SHE:002173 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 717.48 | 781.25 | 816.02 | 805.59 | 709.7 | 711.52 |
Revenue Growth | -11.37% | -4.26% | 1.29% | 13.51% | -0.26% | -1.76% |
Gross Profit Gross Profit Growth | 10.4 | 53.95 | 63.49 | 91.58 | 30.2 | 47.38 |
Operating Income Operating Income Growth | -113.5 | -66.88 | -64.93 | -39.47 | -89.99 | -84.78 |
Net Income Net Income Growth | -76.32 | -34.85 | -93.95 | -34.29 | -73.42 | -103.46 |
Earnings Per Share EPS Growth | -0.16 | -0.08 | -0.21 | -0.08 | -0.16 | -0.23 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Medical Service Business Medical Service Business Growth | 714.84 | 778.09 | 812.14 | 803.89 | 709.7 | 709.37 |
Unallocated Other Business Unallocated Other Business Growth | - | - | 3.88 | 1.69 | - | 2.15 |
Other Other Growth | - | 3.16 | - | - | - | - |
Total Total Growth | 717.48 | 781.25 | 816.02 | 805.59 | 709.7 | 711.52 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 463.48 | 411.59 | 425.78 | 583.16 | 658.48 | 799.75 |
Total Debt Total Debt Growth | 110.48 | 82.29 | 76.18 | 68.54 | 60.15 | 68 |
Net Cash (Debt) Net Cash Growth | 352.99 | 329.3 | 349.6 | 514.62 | 598.33 | 731.75 |
Net Cash Growth | -8.91% | -5.81% | -32.06% | -13.99% | -18.23% | -21.38% |
Net Cash Per Share Net Cash Per Share Growth | 0.76 | 0.76 | 0.78 | 1.20 | 1.34 | 1.63 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -10.28 | 75.93 | -7.34 | 11.03 | -24.45 | 43.37 |
Capital Expenditures CapEx Growth | -47.63 | -84.52 | -46.95 | -96.24 | -123.18 | -110.72 |
Free Cash Flow Free Cash Flow Growth | -57.91 | -8.59 | -54.3 | -85.21 | -147.62 | -67.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 1.45% | 6.91% | 7.78% | 11.37% | 4.26% | 6.66% |
Operating Margin | -15.82% | -8.56% | -7.96% | -4.90% | -12.68% | -11.92% |
Pretax Margin | -10.14% | -3.70% | -12.33% | -4.34% | -10.61% | -14.49% |
Profit Margin | -10.64% | -4.46% | -11.51% | -4.26% | -10.35% | -14.54% |
FCF Margin | -8.07% | -1.10% | -6.65% | -10.58% | -20.80% | -9.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Forward PE | - | 128.39 | 128.39 | 128.39 | 128.39 | 128.39 |
PS Ratio | 10.55 | 12.15 | 4.31 | 4.79 | 4.09 | 5.23 |